Építés alatt – nem éles oldal
Belépés

What researchers published on Tüdőrák

35 940 papers, newest first.

Showing 40 of 35 940

  • Transcutaneous Electrical Acupoint Stimulation Combined with General Anesthesia in Minimally Invasive Surgery for Lung Cancer: A Randomized, Patient- and Assessor-Blinded, Sham-Controlled Trial.Journal of clinical medicine
  • Clinical Utility of Next Generation Sequencing in Concurrent EBUS-TBNA and Liquid Biopsies in NSCLC.American journal of respiratory and critical care medicine
  • Carpobrotus edulis Flower Extract Exerts Cytotoxic and Apoptotic Effects on A-549 Lung Cancer Cells: Phytochemical Profiling and In Silico EGFR Interaction Screening.International journal of molecular sciences
  • TRIM26-Mediated Ubiquitination and Degradation of DDRGK1 Suppress NSCLC Progression by Inhibiting DNA Repair and Promoting Apoptosis.International journal of molecular sciences
  • Co-Occurrence Patterns of Pathological High-Risk Factors and Predictive Value of PET Metabolic Features in Lung Adenocarcinoma: A Retrospective Cohort Study of 1292 Cases.Cancers
  • ÁttekintésBeyond DNA Damage: The Impact of Tobacco Smoke and Its Derivatives on MicroRNAs in Lung Cancer Pathogenesis.Cancers
  • Germline HLA and KIR Variation and Disease Control After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer: Exposure Definition Shapes the Signal.International journal of molecular sciences
  • ÁttekintésMechanism-Matched Pharmacology of Resistance in EGFR-Mutant NSCLC: Genomic Bypass, Lineage Plasticity, Antibody-Drug Conjugates, and Candidate Biophysical Targets.International journal of molecular sciences
  • ÁttekintésReal-World Effectiveness and Safety of Tarlatamab in Small Cell Lung Cancer: A Systematic Review.Cancers
  • Combined Effect of Hadron Therapy and PCSK9 Inhibition Therapy on the Immune Response in STK11-Deficient Lung Adenocarcinoma.International journal of molecular sciences
  • Measured Postoperative DL,CO and FEV1 Frequently Exceed Segment-Count Predictions After Lung Cancer Surgery: A Retrospective Cohort Study.Cancers
  • Real-World Treatment Outcomes and Prognostic Factors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer: A Single-Center Study from a High-Volume Tertiary Chest Hospital.Journal of clinical medicine
  • Comorbidity-Associated N-Glycome Profile Shifts: A Preliminary Study Evaluating COPD and Diabetes in Lung Cancer Patients.Cancers
  • A Preoperative Risk-Prediction Model (SSPAL) for Prolonged Air Leak After Lobectomy for Lung Cancer: Development and Internal Validation.Journal of clinical medicine
  • Tumour Cell-Associated Heterogeneity in Antiviral Immunity Shapes Influenza Responses and Immune-Modulatory Signalling in Lung Cancer.Cancers
  • ÁttekintésTherapeutic Strategies After Immunotherapy Failure in Advanced Non-Small Cell Lung Cancer: Mechanisms of Resistance and Emerging Treatment Approaches.Cancers
  • Selected Demographic and Temperamental Characteristics of Patients with Lung Cancer and Their Associations with Disease Acceptance, Negative Emotional Experiences, and Hope.Cancers
  • ÁttekintésMapping the Epigenetic Regulatory Landscape and Core Transcriptional Axes Across Cell Cycle Phases in Lung Cancer.International journal of molecular sciences
  • Comprehensive Analysis of Next-Generation Sequencing and ARMS-PCR for Detecting EGFR S768 Mutations in Chinese Non-Small Cell Lung Cancer Patients.Diagnostics (Basel, Switzerland)
  • ÁttekintésIntracranial Activity of Deruxtecan-Based Antibody-Drug Conjugates in Non-Small Cell Lung Cancer Brain Metastases: A Systematic Review and Meta-Analysis of Prospective Trial Cohorts.Cancers
  • MRI-Based Radiomics-Clinical Model for Predicting Overall Survival in Lung Cancer Patients: A Single-Center Study.Technology in cancer research & treatment
  • Real-World Clinical Outcomes and Treatment Patterns in Patients with Unresectable Stage III NSCLC Treated with CCRT With or Without Durvalumab as Consolidation Therapy: A Retrospective Cohort Study.Journal of clinical medicine
  • ÁttekintésArtificial Intelligence in Thoracic Surgical Oncology: Technical Foundations and Applications in Lung and Esophageal Cancer Surgery.Cancers
  • Exploratory Integrated Clinical Score and ICF-Defined Functioning in Non-Small Cell Lung Cancer: A Cross-Sectional Study.Journal of clinical medicine
  • EsetismertetésTrousseau Syndrome Manifesting as Recurrent Embolic Stroke in ROS1-Positive Non-Small-Cell Lung Cancer: A Case Report.Journal of clinical medicine
  • ÁttekintésClinical Artificial Intelligence in Non-Small Cell Lung Cancer: From Early Detection and Computational Pathology to Precision Oncology.Cancers
  • Szisztematikus áttekintésRisk prediction models for postoperative pneumonia in lung cancer patients: a systematic review and meta-analysis.Frontiers in oncology
  • Real-World Treatment Patterns and Sequencing of ALK-Inhibitors in ALK-Positive NSCLC Treated with Palliative Intent.Cancers
  • ÁttekintésImmune Cell Landscape in the NSCLC Tumour Microenvironment: Molecular Dysregulation, Crosstalk and Insights into the CEMIP-STAT3-Mediated Immunosuppressive Axis.Cancers
  • ÁttekintésCirculating MicroRNAs in Lung Cancer and Pulmonary Tuberculosis: Diagnostic Potential, Shared Signatures, and Challenges in Differential Diagnosis.Diagnostics (Basel, Switzerland)
  • Endogenous Retrovirus-Targeted Immunotherapy for Non-Small Cell Lung Cancer Supported by Cellular HERV-K Expression, Dependency and Efficacy of ERV Therapy in a Murine Model.International journal of molecular sciences
  • ÁttekintésPrecision Perioperative Treatment for Resectable Non-Small Cell Lung Cancer: Current Status and Perspectives.Cancers
  • ACOT11 Couples Lipid Hydrolysis to GPR40-Associated Metabolic Rewiring and Neutrophil-PD-L1-Associated Immunomodulation in Non-Small Cell Lung Cancer.IUBMB life
  • ÁttekintésThe Role of Surgery in Small-Cell Lung Cancer in the Chemoimmunotherapy Era.Cancers
  • Lung Cancer Mortality and In-Hospital Outcomes in Chile: A Population-Based Cross-Sectional Study.Healthcare (Basel, Switzerland)
  • CUL3-mediated NRF2 dysregulation in TP53-driven non-small cell lung cancer: neddylation-associated structural perturbations.Frontiers in bioinformatics
  • CEACAM7 Promotes Tumor Progression by Regulating GCNT3 Expression in Lung Adenocarcinoma.Cancers
  • Senescence-Related Transcriptomic Analysis and Functional Characterization of ANGPTL4 in Lung Adenocarcinoma.Cancers
  • An immune-resistance dual-axis framework prioritizes MAL2 for functional investigation in lung cancer.Frontiers in pharmacology
  • LLPS-Driven Membraneless Organelle Activity Landscape Reveals Molecular Subtypes, Immune States, and Prognostic Stratification in Lung Adenocarcinoma.International journal of molecular sciences